Submit manuscript at http://omicsgroup.org/journals/submitmanuscript-advances-in-pharmacoepidemiology-drug-safety-open-access.php or send as an e-mail attachment to the Editorial Office at email@example.com
Impact Factor: 1.37*
Advances in Pharmacoepidemiology & Drug Safety journal offers vital opportunities to researchers and scientist to explore the advanced and the latest research in the field of Pharmacoepidemiology and Drug Safety. This peer reviewed journal includes a wide range of fields like drug therapies, evaluation of drugs, effects, assessment of risk vs. benefit ratios in drug therapy, formulation and interpretation of regulatory guidelines, advancements in the drugs and therapeutic solutions and drug safety. Pharmacoepidemiology is a scholarly Open Access journal that aims to publish the most complete and reliable source of information in related fields.
Pharmacoepidemiology Journal strives to enhance the intelligence and information dissemination on topics closely related to Pharmacoepidemiology, Pharmacokinetics, Adverse drug reactions, Public health, Epidemiologic methods, Medication adherence and Drug safety.The journal provides a unique forum dedicated to scientists to express their findings as research articles, review articles, case reports and short communications on an array of Pharmacoepidemiology and Drug Safety topics.Universally prominent Editorial Board members supervise the Peer Review process for Journal of Pharmacoepidemiology.
Pharmacoepidemiology journal’s impact factors is mainly calculated based on the number of articles published after the single blind peer review, essence of the work and the number of citations received for the published articles. Abstracts and full texts of all the articles published are freely accessible to everyone immediately after publication.Editorial board members of the APDS or outside experts review manuscripts; at least two independent reviewer’s approval followed by the editor is required for the acceptance of any citable manuscript.
Submit manuscript at http://editorialmanager.com/pharma/ or send as an e-mail attachment to the Editorial Office at
Adverse drug reactions is that unwanted or harmful reaction which is experienced after the administration of a drug or combination of medicine under normal conditions of use. Adverse drug reactions embrace rashes, jaundice, anemia, a decrease in the white white blood cell count, kidney damage, and nerve injury that will impair vision or hearing. Affected people is also allergic or supersensitized to the drug owing to genetic variations in the way their body metabolizes or responds to medicine.
Drug safety regulations incorporates several mutually reinforcing activities all geared toward promoting and protective public health. These activities vary from country to country in scope and implementation. It demands the application of sound medical, scientific and technical data and skills that will operates within a legal framework.
Drug safety databases contain professional assessment of the potential of drugs. This database permits the risk- profit analysis of medicinal products taking under consideration new and emerging information, within the context of additive data. Drug safety database offers programming of alerts for fast cases, follow-up cases and reports submission to fulfill regulative timeline compliance.
Clinical pharmacoepidemiological trails offer important information concerning the positive and negative effects of any drug, leading to a higher analysis of the risk/ profit magnitude relation for the use of a drug in a patient.
Pharmacoepidemiologic studies offer assessments of potential short and long-run adverse drug events within the general population with a wide range of health status and demographic characteristics and with a way longer follow-up period than clinical trials, that measure initial drug effectiveness and safety. It embody live population primarily based benefits and risks of drug in large numbers of individuals. Studies includes the analysis of prescribing medication and its determinant factors, implementation of pharmaco-epidemiologic information into action, describe and analyze the economics of drug use and to advise decision-makers.
Pharmacotherapy, also called drug therapy, is a general term for using medication to treat disease. Drugs interact with receptors or enzymes in cells to promote healthy functioning and reduce or cure illness. It is employed to treat a range of psychological disorders, as well as attention hyperactivity disorder, major depression, schizophrenic psychosis, anxiety disorders, autism, panic attacks and neurotic disorder among several others.
Drug safety information maintenance maintains periodic report preparation method so as to enable the surveillance and signal detection that allows for the delivery of greater patient safety.
Expert Opinion on Drug Safety is a bimonthly journal that publishes review articles on comprehensive coverage of safety of latest and established drug therapies. It seeks to unravel this huge quantity of data and supply clear and informed guides to this increasingly important area.
Reviews on drug safety contains reviews on the epidemiology, clinical features, prevention and management of adverse effects of individual medication and drug categories. This gives an in-depth review of adverse impact and effectiveness information for a drug in an exceedingly outlined therapeutic area.
US Drug safety regulations incorporates several mutually reinforcing activities all geared towards promoting and protective public health. All medicines should meet 3 criteria: be of fine quality, safe and effective.
Europeon drug safety regulations involves varied mutually reinforcing activities all geared toward promoting and protective public health. These regulative functions involve interactions with various stakeholders whose economic, social and political motives could dissent, creating implementation of regulation each politically and technically difficult.
Anvisa is a drug regulative body of Brazil. It aims to guard and promote health, guaranteeing the hygiene and safety of products and services. It also moniters and follow up the event of activities administered by the National Health Surveillence Agency.
UK drug safety regulations aims at streamlining monitoring processes and improving surveillance by introducing new tools like post authorisation efficacy studies, the creation of the Pharmacovigilance Risk Assessment Committee at the European Medicines Agency and also the assortment and analysis of an excellent broader body of safety knowledge.
Japan Drug safety regulations incorporates several mutually reinforcing activities all aimed at promoting and protecting public health.
Patient safety is the prevention of avoidable errors and adverse effects to patients associated with health care. Staff practise patient safety when they apply safety science methods towards the goal of developing reliable systems of care.
Drug delivery refers to approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effect. It control the rate at which a drug is released and the location in the body where it is release.
Medication errors are any preventable event that may cause or lead to inappropriate medication use or patient harm while the medication is in the control of the health care professional, patient, or consumer. Medication errors can be classified, invoking psychological theory, as knowledge-based mistakes, rule-based mistakes, action-based slips, and memory-based lapses.
Public health is the science of protecting and improving the health of families and communities through promotion of healthy lifestyles, research for disease and injury prevention and detection and control of infectious diseases.
OMICS International is a leading Open Access publisher and scientific event organizer that take pride in welcoming the researchers and contributors across the globe to its 4th International Conference and Exhibition on Pharmacovigilance & Clinical Trials to be held during August 10-12, 2015 at London, UK.
*Unofficial 2014 Impact Factor was established by dividing the number of articles published in 2012 and 2013 with the number of times they are cited in 2014 based on Google search and the Scholar Citation Index database. If ‘X’ is the total number of articles published in 2012 and 2013, and ‘Y’ is the number of times these articles were cited in indexed journals during 2014 than, impact factor = X/Y